TAG ARCHIVES FOR COVID-19

19
Oct2020

The COVID-19 pandemic has brought many issues to the public’s attention that used to be of interest only to clinical research and drug development communities: clinical trial design, efficiency and timelines of clinical research studies, drugs’ approval process, and pre-approval access to investigational therapies are just a few. Read more

13
Oct2020

On June 18, 2020, PRIM&R hosted a webinar, Complexity in Clinical Trial Design: A Primer on Adaptive and Platform Trials. During this webinar, Luke Gelinas and Marianne Kearney Chase defined key terms, explored ethical and regulatory challenges, and provided strategies and examples to bridge the gap between IRBs and researchers in understanding adaptive trial designs. Following the webinar, Luke and Marianne reflected on the session and attendee feedback; we're pleased to share their response with the readers of Ampersand. Read more

17
Aug2020

As the world eagerly awaits a coronavirus vaccine, the vital role of biomedical research has become increasingly visible. But as researchers—whether they study humans or nonhuman animals—enjoy increased prominence and (in some corners) approval, the challenges of doing their work remain immense. And at a time like this, maintaining the highest ethical standards in research is more crucial than ever. Read more